Search Immortality Topics:

Page 11234..1020..»


Category Archives: Global News Feed

Golden Leaf Holdings Announces First Cashflow-Positive Quarter and Record Quarterly Revenues

Operational Excellence a key driver of financial results Operational Excellence a key driver of financial results

See the rest here:
Golden Leaf Holdings Announces First Cashflow-Positive Quarter and Record Quarterly Revenues

Posted in Global News Feed | Comments Off on Golden Leaf Holdings Announces First Cashflow-Positive Quarter and Record Quarterly Revenues

Tarsus Pharmaceuticals, Inc. Appoints Wendy Yarno to Board of Directors

IRVINE, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced the appointment of Wendy L. Yarno to its Board of Directors and its audit committee. Ms. Yarno has more than 30 years of experience in the biopharmaceutical industry, as a public company director and product commercialization leader, including 26 years at Merck & Co. Inc.

The rest is here:
Tarsus Pharmaceuticals, Inc. Appoints Wendy Yarno to Board of Directors

Posted in Global News Feed | Comments Off on Tarsus Pharmaceuticals, Inc. Appoints Wendy Yarno to Board of Directors

Affimed Announces Publication of Final Study Results of its Innate Cell Engager Candidate AFM13 in Combination with MSD’s anti-PD-1 therapy…

See the original post here:
Affimed Announces Publication of Final Study Results of its Innate Cell Engager Candidate AFM13 in Combination with MSD’s anti-PD-1 therapy...

Posted in Global News Feed | Comments Off on Affimed Announces Publication of Final Study Results of its Innate Cell Engager Candidate AFM13 in Combination with MSD’s anti-PD-1 therapy…

PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Strategy

Original post:
PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Strategy

Posted in Global News Feed | Comments Off on PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Strategy

Codiak BioSciences Reports Third Quarter 2020 Financial Results and Operational Progress

– Human clinical testing now underway with Codiak’s first two candidates, exoIL-12™ and exoSTING™ –

See original here:
Codiak BioSciences Reports Third Quarter 2020 Financial Results and Operational Progress

Posted in Global News Feed | Comments Off on Codiak BioSciences Reports Third Quarter 2020 Financial Results and Operational Progress

Phathom Pharmaceuticals to Host Virtual Investor Day

FLORHAM PARK, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, today confirmed it will host a virtual Investor Day on December 14, 2020 from 1 pm to 3:30 pm Eastern Time. Members of Phathom’s management team and gastroenterology key opinion leaders will provide updates on the company’s pipeline and commercial strategy.

More:
Phathom Pharmaceuticals to Host Virtual Investor Day

Posted in Global News Feed | Comments Off on Phathom Pharmaceuticals to Host Virtual Investor Day